Source: Annual Congress 2005 - Gene expression, receptors and markers in lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Lloret, A. Rosell, N. Rodríguez, E. Arellano, S. Calvo, M. T. Fernández, J. Ruiz, J. L. Ramírez, J. Gupta, M. Taron, R. Rosell (Barcelona, Spain). Dysplasia and aberrant methylation profiles in risk and lung cancer patients. Eur Respir J 2005; 26: Suppl. 49, 2924

Member's Comments

No comment yet.

Related content which might interest you: Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Association of the PDCD5 locus with lung cancer risk and prognosis in smokers Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 Aberrant methylation in lung cancer identified by EBUS-TBNA as a marker of advanced staging Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Microsatellite alterations in cell-free body fluids for the discrimination of lung cancer patients from patients with benign lung diseases Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 CD44v6 expression in tissue of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Metabolic reprogramming and the risk of lung cancer Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink Year: 2017 Earlier stages, higher incidence of squamous and lower incidence of small cell and adenocarcinomas among lung cancer patients with coexisting COPD Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Analysis of the patients with primary lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 562s Year: 2007